Paper40744899
The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system.
Li T and 7 others. Brain Pathol, 2026. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system. Papers, record 40744899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40744899
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sphingolipids | Major topic |
| Signal Transduction | Major topic |
| Central Nervous System | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2025AFC006 | Natural Science Foundation of Hubei Province | PubMed | ||
| 2024AFB723 | Natural Science Foundation of Hubei Province | PubMed | ||
| 2022CFB195 | Natural Science Foundation of Hubei Province | PubMed | ||
| ZR2019BH056 | Natural Science Foundation of Shandong Province | PubMed | ||
| PTXM2025032 | Medical Sci-Tech Innovation Platform of Zhongnan Hospital, Wuhan University | PubMed | ||
| PTXM2023009 | Medical Sci-Tech Innovation Platform of Zhongnan Hospital, Wuhan University | PubMed | ||
| PTXM2024025 | Medical Sci-Tech Innovation Platform of Zhongnan Hospital, Wuhan University | PubMed |
Source PubMed
References283
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23254192 | The many faces of α-synuclein: from structure and toxicity to therapeutic target. | Nat Rev Neurosci | 2013 | https://conductscience.org/library/papers/23254192 | PubMed |
| 2 | 21942574 | Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. | Chem Rev | 2011 | https://conductscience.org/library/papers/21942574 | PubMed |
| 3 | 9989456 | Oxidative alterations in Alzheimer's disease. | Brain Pathol | 1999 | https://conductscience.org/library/papers/9989456 | PubMed |
| 4 | 19937366 | The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients. | J Neurooncol | 2010 | https://conductscience.org/library/papers/19937366 | PubMed |
| 5 | 37475643 | Regulation of lipid synthesis in myelin modulates neural activity and is required for motor learning. | Glia | 2023 | https://conductscience.org/library/papers/37475643 | PubMed |
| 6 | 25762012 | GM1 Ganglioside: Past Studies and Future Potential. | Mol Neurobiol | 2016 | https://conductscience.org/library/papers/25762012 | PubMed |
| 7 | 37349971 | MiR-199a-5p enhances neuronal differentiation of neural stem cells and promotes neurogenesis by targeting Cav-1 after cerebral ischemia. | CNS Neurosci Ther | 2023 | https://conductscience.org/library/papers/37349971 | PubMed |
| 8 | 26921668 | Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions. | Neurochem Int | 2016 | https://conductscience.org/library/papers/26921668 | PubMed |
| 9 | 18700282 | Spatial memory formation induces recruitment of NMDA receptor and PSD-95 to synaptic lipid rafts. | J Neurochem | 2008 | https://conductscience.org/library/papers/18700282 | PubMed |
| 10 | 35855333 | Crosstalk between Lipid Rafts and Aging: New Frontiers for Delaying Aging. | Aging Dis | 2022 | https://conductscience.org/library/papers/35855333 | PubMed |
| 11 | 30953657 | Ceramide synthases in cancer therapy and chemoresistance. | Prog Lipid Res | 2019 | https://conductscience.org/library/papers/30953657 | PubMed |
| 12 | 34933294 | An electroceutical approach enhances myelination via upregulation of lipid biosynthesis in the dorsal root ganglion. | Biofabrication | 2022 | https://conductscience.org/library/papers/34933294 | PubMed |
| 13 | 35805142 | Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives. | Cells | 2022 | https://conductscience.org/library/papers/35805142 | PubMed |
| 14 | 37582160 | A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P1 signaling axis. | Sci Signal | 2023 | https://conductscience.org/library/papers/37582160 | PubMed |
| 15 | 31751571 | FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models. | Exp Neurol | 2020 | https://conductscience.org/library/papers/31751571 | PubMed |
| 16 | 24346695 | Sphingosine 1-phosphate signalling. | Development | 2014 | https://conductscience.org/library/papers/24346695 | PubMed |
| 17 | 31624181 | Sphingosine 1-phosphate: Lipid signaling in pathology and therapy. | Science | 2019 | https://conductscience.org/library/papers/31624181 | PubMed |
| 18 | 39125841 | Sphingosine 1-Phosphate Stimulates ER to Golgi Ceramide Traffic to Promote Survival in T98G Glioma Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125841 | PubMed |
| 19 | 37151139 | Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist. | J Clin Neurol | 2023 | https://conductscience.org/library/papers/37151139 | PubMed |
| 20 | 514451 | The fragility of cerebral lysosomes in multiple sclerosis. | Neuropathol Appl Neurobiol | 1979 | https://conductscience.org/library/papers/514451 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794556 | Combined Modulation of Ceramide and S1P Pathways Induces Strong Cytotoxicity in SH-SY5Y Neuroblastoma Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794556 | PubMed |
| 42652197 | Sphingolipid Metabolism in Oral Diseases: Pathogenic Mechanisms, Biomarkers, and Therapeutic Opportunities. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652197 | PubMed |
| 42571676 | From invasive nuisance to biotechnological asset: LC-MS/MS chemical profiling and pharmacological potential of ascidian Styela plicata from Albufeira Lagoon, Portugal. | Environ Sci Pollut Res Int | 2026 | https://conductscience.org/library/papers/42571676 | PubMed |
| 42540554 | Serum metabolomic profiling identifies a biomarker panel associated with age-related hearing loss. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42540554 | PubMed |
| 42365207 | A multi-ingredient food supplement slows age-dependent decline of mobility and influences gene expression in C. elegans. | Biogerontology | 2026 | https://conductscience.org/library/papers/42365207 | PubMed |
| 42239376 | A lipid compendium of a metabolically compromised bacterium provides insights into lipid acquisition, biosynthesis, and metabolism. | bioRxiv | 2026 | https://conductscience.org/library/papers/42239376 | PubMed |
| 42221032 | Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42221032 | PubMed |
| 42147971 | Decoding the S1P-S1PR axis in cancer: Mechanisms, pathways and therapeutic horizons (Review). | Biomed Rep | 2026 | https://conductscience.org/library/papers/42147971 | PubMed |
| 42088539 | Sphingomyelin synthase 1 as a potential upstream amplifier of microglial CSF1R signaling in neuropathic pain. | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/42088539 | PubMed |
| 41750606 | Aspirin Eugenol Ester Alleviates Gastric Injury by Inhibiting Ferroptosis and Oxidative Stress. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41750606 | PubMed |
| 41469705 | Border-associated macrophages: an emerging perspective from physiological basis and multi-disease roles to the mechanism of vascular cognitive impairment and dementia. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/41469705 | PubMed |
| 40744899 | The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system. | Brain Pathol | 2026 | https://conductscience.org/library/papers/40744899 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40744899
GET https://conductscience.org/api/papers/v1/40744899/references?page=2